Please provide your email address to receive an email when new articles are posted on . Retia Medical announced that a cardiac output monitoring device for patients who are at high surgical risk or ...
The FDA granted a 510(k) clearance to Retia Medical’s hemodynamic monitoring device for measuring a patient’s cardiac output in intensive care units or the operating room. The Valhalla, New York-based ...
VitalStream is an FDA-cleared wireless, wearable monitor for continuous blood pressure and advanced hemodynamics. VitalStream application with advanced hemodynamic parameters. Noninvasive cardiac ...
Surgical and intensive care patients face a higher risk of death and longer hospital stays because they are susceptible to both hypotension and hemodynamic instability – or unstable blood flow. These ...
Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian ...
Ottawa, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The global wearable cardiac devices market size is predicted to surpass USD 32.16 billion by 2034, increasing from USD 5.84 billion in 2026. The market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results